{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=GI+Disorders&page=6", "query": { "condition": "GI Disorders", "page": 6 }, "page_size": 10 }, "pagination": { "page": 6, "page_size": 10, "total_count": 8147, "total_pages": 815, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=GI+Disorders&page=7&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=GI+Disorders&page=5&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T05:34:15.856Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00032305", "title": "Research Study in Patients With Severe Ulcerative Colitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "Visilizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Facet Biotech", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 20, "start_date": "2002-03", "completion_date": "2005-11", "has_results": false, "last_update_posted_date": "2012-03-07", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 7, "location_summary": "Los Angeles, California • San Francisco, California • Atlanta, Georgia + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00032305" }, { "nct_id": "NCT06424522", "title": "A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Low Anterior Resection Syndrome", "Rectal Carcinoma" ], "interventions": [ { "name": "Dietary Fiber", "type": "DIETARY_SUPPLEMENT" }, { "name": "Enema Administration", "type": "PROCEDURE" }, { "name": "Loperamide Hydrochloride", "type": "DRUG" }, { "name": "Physical Therapy", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "X-Ray Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "Ohio State University Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2027-02-15", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT06424522" }, { "nct_id": "NCT05736705", "title": "Monopolar and Bipolar in Esophageal ESD", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Esophageal Neoplasm", "Esophageal Polyp", "Endoscopic Submucosal Dissection", "Bipolar Electocautery" ], "interventions": [ { "name": "Endoscopic Submucosal Dissection", "type": "PROCEDURE" }, { "name": "Bipolar electrocautery knife", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "DEVICE" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 0, "start_date": "2023-01-23", "completion_date": "2024-06-25", "has_results": false, "last_update_posted_date": "2024-06-27", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05736705" }, { "nct_id": "NCT05489237", "title": "First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Gastrointestinal Neoplasms", "Gastrointestinal Stromal Tumor (GIST)", "Digestive System Disease", "Gastrointestinal Diseases", "Metastatic Cancer" ], "interventions": [ { "name": "IDRX-42", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "IDRX, Inc., a wholly owned subsidiary of GSK, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 276, "start_date": "2022-08-03", "completion_date": "2027-03-26", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 8, "location_summary": "Miami, Florida • Chicago, Illinois • Boston, Massachusetts + 5 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05489237" }, { "nct_id": "NCT03849469", "title": "A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Melanoma", "Cervical Carcinoma", "Pancreatic Carcinoma", "Triple Negative Breast Cancer", "Hepatocellular Carcinoma", "Urothelial Carcinoma", "Squamous Cell Carcinoma of the Head and Neck", "Nasopharyngeal Carcinoma", "Renal Cell Carcinoma", "Non-small Cell Lung Carcinoma", "Small Cell Lung Carcinoma", "Gastric or Gastroesophageal Junction Adenocarcinoma", "Advanced or Metastatic Solid Tumors", "Prostate Carcinoma", "Epithelial Ovarian Cancer", "Fallopian Tube Cancer", "Primary Peritoneal Carcinoma", "Intrahepatic Cholangiocarcinoma", "Squamous Cell Anal Cancer", "Squamous Cell Penile Carcinoma", "Squamous Cell Vulvar Carcinoma", "Colorectal Carcinoma", "Endometrial Carcinoma" ], "interventions": [ { "name": "XmAb®22841", "type": "BIOLOGICAL" }, { "name": "Pembrolizumab (Keytruda®)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Xencor, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 78, "start_date": "2019-05-29", "completion_date": "2023-02-16", "has_results": false, "last_update_posted_date": "2023-03-30", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 28, "location_summary": "Encinitas, California • La Jolla, California • Los Angeles, California + 15 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03849469" }, { "nct_id": "NCT05345054", "title": "The Deep South Surgical Equity Research Network: Addressing Socioecological Determinants of Health", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer", "Inflammatory Bowel Diseases", "Diverticular Diseases", "Social Behavior" ], "interventions": [ { "name": "no intervention", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2022-08-01", "completion_date": "2023-08-12", "has_results": false, "last_update_posted_date": "2023-08-18", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 3, "location_summary": "Alexander City, Alabama • Demopolis, Alabama • Greenville, Alabama", "locations": [ { "city": "Alexander City", "state": "Alabama" }, { "city": "Demopolis", "state": "Alabama" }, { "city": "Greenville", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05345054" }, { "nct_id": "NCT06184594", "title": "Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Colorectal Cancer Screening" ], "interventions": [ { "name": "eNav", "type": "OTHER" }, { "name": "Standard of Care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 400, "start_date": "2024-01-24", "completion_date": "2027-04-30", "has_results": false, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06184594" }, { "nct_id": "NCT02406651", "title": "Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Graft vs Host Disease" ], "interventions": [ { "name": "Recombinant Human Interleukin-22 IgG2-Fc (F-652)", "type": "DRUG" }, { "name": "Systemic Corticosteroids", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "EVIVE Biotechnology", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2016-05-12", "completion_date": "2020-03-08", "has_results": true, "last_update_posted_date": "2021-07-22", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 3, "location_summary": "Duarte, California • New York, New York • Houston, Texas", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "New York", "state": "New York" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02406651" }, { "nct_id": "NCT05613153", "title": "Peppermint Oil as a Treatment for Children With Bladder and Bowel Dysfunction", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bladder and Bowel Dysfunction" ], "interventions": [ { "name": "Peppermint Oil", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Children's Hospital of Orange County", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "8 Years to 17 Years" }, "enrollment_count": 30, "start_date": "2022-11-01", "completion_date": "2026-12-31", "has_results": false, "last_update_posted_date": "2026-04-08", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 1, "location_summary": "Orange, California", "locations": [ { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05613153" }, { "nct_id": "NCT04516083", "title": "Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer Gene Mutation", "Lynch Syndrome", "Endometrial Cancer", "Somatic Mutation" ], "interventions": [ { "name": "Mismatch repair instability somatic and germline testing", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "RWJ Barnabas Health at Jersey City Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 100, "start_date": "2019-12-21", "completion_date": "2021-06-30", "has_results": false, "last_update_posted_date": "2020-08-18", "last_synced_at": "2026-10-23T05:34:15.856Z", "location_count": 1, "location_summary": "Jersey City, New Jersey", "locations": [ { "city": "Jersey City", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT04516083" } ] }